Latest development of PARP inhibitors in ovarian cancer

被引：0
|
作者：
Harano, Kenichi [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Dev Therapeut Breast Med Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz336.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MS3 - 5
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Latest clinical evidence and further development of PARP inhibitors in ovarian cancer
    Mirza, M. R.
    Pignata, S.
    Ledermann, J. A.
    ANNALS OF ONCOLOGY, 2018, 29 (06) : 1366 - 1376
  • [2] Clinical development of PARP inhibitors in ovarian cancer
    Fujiwara, Keiichi
    ANNALS OF ONCOLOGY, 2022, 33 : S447 - S447
  • [3] PARP Inhibitors in Ovarian Cancer
    Mittica, Gloria
    Ghisoni, Eleonora
    Giannone, Gaia
    Genta, Sofia
    Aglietta, Massimo
    Sapino, Anna
    Valabrega, Giorgio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2018, 13 (04) : 392 - 410
  • [4] PARP inhibitors in ovarian cancer
    David Cibula
    Judith Balmaña
    British Journal of Cancer, 2015, 113 : S1 - S2
  • [5] PARP inhibitors in ovarian cancer
    Goldlust, Ian S.
    Guidice, Elena
    Lee, Jung-min
    SEMINARS IN ONCOLOGY, 2024, 51 (1-2) : 45 - 57
  • [6] PARP Inhibitors in Ovarian Cancer
    Dekker, Tim J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1573 - 1574
  • [7] PARP Inhibitors for Ovarian Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1535): : 200 - 202
  • [8] PARP INHIBITORS IN OVARIAN CANCER
    Calvert, H.
    Curtin, N.
    Plummer, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 23 - 23
  • [9] PARP inhibitors in ovarian cancer
    Ledermann, J. A.
    ANNALS OF ONCOLOGY, 2016, 27 : 40 - 44
  • [10] PARP inhibitors in ovarian cancer
    Franzese, Elisena
    Centonze, Sara
    Diana, Anna
    Carlino, Francesca
    Guerrera, Luigi Pio
    Di Napoli, Marilena
    De Vita, Ferdinando
    Pignata, Sandro
    Ciardiello, Fortunato
    Orditura, Michele
    CANCER TREATMENT REVIEWS, 2019, 73 : 1 - 9
12345